U
PBH icon

UBS’s Prestige Consumer Healthcare PBH Stock Holding History

UBS’s Portfolio PBH Stock Details PBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$457K Sell
14,112
-2,151
-13% -$72K ﹤0.01% 4376
2014
Q2 		$551K Buy
16,263
+188
+1% +$6.02K ﹤0.01% 4138
2014
Q1 		$438K Buy
16,075
+10,450
+186% +$310K ﹤0.01% 4378
2013
Q4 		$201K Sell
5,625
-293
-5% -$9.73K ﹤0.01% 5283
2013
Q3 		$178K Sell
5,918
-10,266
-63% -$336K ﹤0.01% 5329
2013
Q2 		$472K Buy
+16,184
New +$456K ﹤0.01% 4159

Other funds holding PBH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

UBS's PBH Position: Q3 2014 in Review

UBS reduced its Prestige Consumer Healthcare (PBH) stake by 13% in Q3 2014, selling an estimated $72K and leaving 14,112 shares worth $457K. The position accounts for ﹤0.01% of the portfolio, ranked #4376.

UBS first reported a position in PBH in Q2 2013 and has held it in 6 quarters since. The position peaked at $551K in Q2 2014. 174 funds tracked by Wall St. Rank hold PBH as of Q3 2014.

  • UBS held 14,112 shares of Prestige Consumer Healthcare worth $457K as of Q3 2014.
  • UBS sold 2,151 Prestige Consumer Healthcare shares in Q3 2014, an estimated $72K.
  • Prestige Consumer Healthcare made up ﹤0.01% of UBS's portfolio in Q3 2014, its #4376 holding.
  • UBS first reported a position in Prestige Consumer Healthcare in Q2 2013 and has held it in 6 quarters since.
  • UBS's Prestige Consumer Healthcare position peaked at $551K in Q2 2014.
  • 174 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.